Mark N. Lampert, 10% Owner at RIGEL PHARMACEUTICALS INC (RIGL), bought 32,700 shares at $3.47 ($113K) on 2013-06-07, disclosed to the SEC on 2013-06-11.
Open-market purchase of $113k RIGL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.47 | 8,102 | $28K | 24.8% |
| 2 | $3.47 | 24,598 | $85K | 75.2% |
| Total | $3.47 avg | 32,700 | $113K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |